Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002121
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
Diethylhomospermine DEHSPM for Refractory AIDS-Related Diarrhea
Sponsor:
VA Medical Center-Gainesville
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
Diethylhomospermine DEHSPM for Refractory AIDS-Related Diarrhea
Status:
COMPLETED
Status Verified Date:
1996-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To perform preliminary clinical testing of diethylhomospermine DEHSPM a polyamine analogue for refractory AIDS-related diarrhea
Possibly DEHSPM will reduce stool volume and frequency in patients with refractory AIDS-related diarrhea
Possibly DEHSPM will reduce stool volume and frequency in patients with refractory AIDS-related diarrhea
Detailed Description:
Possibly DEHSPM will reduce stool volume and frequency in patients with refractory AIDS-related diarrhea
Patients are initially hydrated for 24 hours followed by a 3-day baseline period They then receive intravenous infusions of DEHSPM three times per day for 3 days followed by observation for 3 days
Patients are initially hydrated for 24 hours followed by a 3-day baseline period They then receive intravenous infusions of DEHSPM three times per day for 3 days followed by observation for 3 days
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: